Illumina Inc (NASDAQ:ILMN)
| CAPS Rating |
|
|---|---|
| Open | $52.42 |
| Previous Close | $53.17 |
| Daily Range | $52.35 - $53.95 |
| 52-Week Range | $25.57 - $79.40 |
| Market Cap | $6.70B |
| P/E Ratio | 30.10 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 2,246,257 |
| Average Daily Volume | 0 |
ILMN
VS S&P 500 (SPY)
How do you think ILMN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ILMN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ILMN News and Commentary
- Affymetrix Misses as Sales Dip - Analyst Blog – NASDAQ
- Illuminating the Way Forward for Genomics – The Motley Fool
- Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina an – NASDAQ
- Life Technologies' Sequence of Success – The Motley Fool
- Life Technologies Beats, Profit Up - Analyst Blog – NASDAQ
- Roche Hostile Bid for Illumina is Just Getting Started – Minyanville
- Illumina Beats, Spurns Roche Offer - Analyst Blog – NASDAQ
- Illumina Beats on EPS but GAAP Results Lag – The Motley Fool
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Roche Disappointed At Illumina Board Stance On Tender Offer – SmartMoney
- 3rd UPDATE: Illumina Rejects $5.7 Billion Roche Offer As Inadequate; 4Q Net Off 70% – SmartMoney
- 2nd UPDATE: Illumina Rejects $5.7 Billion Roche Offer As Inadequate; 4Q Net Off 70% – SmartMoney
- UPDATE: Illumina Rejects $5.7 Billion Roche Offer As Inadequate; 4Q Net Off 70% – SmartMoney
- Illumina Rejects $5.7 Billion Roche Offer As Inadequate – SmartMoney
- Genomic Misses, Grows Annually - Analyst Blog – NASDAQ
- Earnings Preview: Life Technologies - Analyst Blog – NASDAQ
- Industrial Giant Taps Into America's Energy Grid – The Motley Fool
- UPDATE: Roche Upbeat On Outlook As Profit Rises – SmartMoney
- Roche Upbeat On Outlook As Profit Rises – SmartMoney
- UPDATE: Roche Plans To Nominate Candidates To Illumina Board – SmartMoney
RSS Headlines
Fool UK
